Company Highlights

All
Announcements
Press Releases
In The News

Announcement
Integrated Nanotherapeutics is presenting at Breakthrough T1D Clinical & Research Congress 2026, October 9-11, in Philadelphia, PA.

October 1, 2026

In the News
Integrated Nanotherapeutics is proud to be selected as one of Life Sciences BC 2026 “Companies to Watch”.

September 10, 2026

Announcement
Integrated Nanotherapeutics will be partnering at RESI Boston 2026, Sept 22-23, in Boston, MA.

September 8, 2026

Announcement
Integrated Nanotherapeutics is invited to exhibit at World Health Expo (WHX) Osaka 2026, July 2-4, in Osaka, Japan.

June 22, 2026

Announcement
Integrated Nanotherapeutics welcomes Dr. Carmella Evans-Molina to the Scientific Advisory Board.

June 18, 2026

In The News
Integrated Nanotherapeutics is featured by Pacific Economic Development Canada (PacifiCan) with an exclusive interview with our CEO, Chris Tam.

June 16, 2026

Announcement
Integrated Nanotherapeutics will be partnering at BIO International 2026, June 22-25, in San Diego, CA.

June 10, 2026

Announcement
Integrated Nanotherapeutics will be exhibiting at Web Summit 2026, May 11-14, in Vancouver, BC.

May 6, 2026

Announcement
Integrated Nanotherapeutics will be speaking at the 21st Immunology of Diabetes Society Congress & Australian Islet Study Group Meeting (IDS) 2026, Apr 20-24, in Brisbane, Australia.

April 20, 2026

Press Release
Integrated Nanotherapeutics
Secures Genome Canada GAPP Funding to Advance Multi-Cargo mRNA/LNP Therapy for Type 1 Diabetes Toward the Clinic.

March 18, 2026

Announcement
Integrated Nanotherapeutics will be speaking at the 9th Antigen-Specific Immune Tolerance Summit (ASIT) 2026 Annual Meeting, Mar 3-6, in Boston.

March 3, 2026

Announcement
Integrated Nanotherapeutics will be attending Biotech Showcase 2026 during JPM Week, Jan 13 – 15, in San Francisco.

January 12, 2026

Announcement
Integrated Nanotherapeutics will be speaking at the 8th Antigen-Specific Immune Tolerance Summit (ASIT) 2025, Feb 25 – 27, in Boston.

February 25, 2025

Announcement
Integrated Nanotherapeutics will be attending Biotech Showcase 2025 during JPM Week, Jan 13 – 15, in San Francisco.

January 13, 2025

Press Release
Integrated Nanotherapeutics and Breakthrough T1D Collaborate to Advance Development of an Immune Tolerizing Therapeutic to Treat Type 1 Diabetes.

September 9, 2024

Press Release
Integrated Nanotherapeutics is presenting T1D preclinical data at the Federation of Clinical Immunology Societies (FOCIS) 2024 Annual Meeting, June 18 – 21, in San Francisco.

June 11, 2024